Caitong International Asset Management’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52 Buy
40
+33
+471% +$45 ﹤0.01% 2341
2026
Q1
$9 Buy
7
+6
+600% +$10 ﹤0.01% 2163
2025
Q4
$2 Sell
1
-1,792
-100% -$3.37K ﹤0.01% 1823
2025
Q3
$2.9K Buy
1,793
+1,515
+545% +$3.17K ﹤0.01% 1335
2025
Q2
$720 Buy
278
+186
+202% +$734 ﹤0.01% 1641
2025
Q1
$619 Buy
+92
New +$651 ﹤0.01% 1719

Other funds holding LUNG

Caitong International Asset Management's LUNG Position: Q2 2026 in Review

Caitong International Asset Management increased its Pulmonx (LUNG) stake by 471% in Q2 2026, buying an estimated $45 and bringing the position to 40 shares worth $52. The position accounts for ﹤0.01% of the portfolio, ranked #2341.

Caitong International Asset Management first reported a position in LUNG in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.9K in Q3 2025. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Caitong International Asset Management held 40 shares of Pulmonx worth $52 as of Q2 2026.
  • Caitong International Asset Management bought 33 Pulmonx shares in Q2 2026, an estimated $45.
  • Pulmonx made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2341 holding.
  • Caitong International Asset Management first reported a position in Pulmonx in Q1 2025 and has held it in 6 quarters since.
  • Caitong International Asset Management's Pulmonx position peaked at $2.9K in Q3 2025.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.